PL341090A1 - Cyclic derivatives of peptides as adhesion inhibitors - Google Patents

Cyclic derivatives of peptides as adhesion inhibitors

Info

Publication number
PL341090A1
PL341090A1 PL98341090A PL34109098A PL341090A1 PL 341090 A1 PL341090 A1 PL 341090A1 PL 98341090 A PL98341090 A PL 98341090A PL 34109098 A PL34109098 A PL 34109098A PL 341090 A1 PL341090 A1 PL 341090A1
Authority
PL
Poland
Prior art keywords
peptides
cyclic derivatives
adhesion inhibitors
inhibitors
adhesion
Prior art date
Application number
PL98341090A
Other languages
English (en)
Inventor
Guenter Hoelzemann
Simon Goodman
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PL341090A1 publication Critical patent/PL341090A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL98341090A 1997-08-23 1998-08-14 Cyclic derivatives of peptides as adhesion inhibitors PL341090A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19736772A DE19736772A1 (de) 1997-08-23 1997-08-23 Cyclopeptidderivate
PCT/EP1998/005161 WO1999010371A2 (de) 1997-08-23 1998-08-14 Cyclopeptidderivate als adhäsionsinhibitoren

Publications (1)

Publication Number Publication Date
PL341090A1 true PL341090A1 (en) 2001-03-26

Family

ID=7839977

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98341090A PL341090A1 (en) 1997-08-23 1998-08-14 Cyclic derivatives of peptides as adhesion inhibitors

Country Status (18)

Country Link
EP (1) EP1007545A2 (pt)
JP (1) JP2001514186A (pt)
KR (1) KR20010022828A (pt)
CN (1) CN1267306A (pt)
AR (1) AR013650A1 (pt)
AU (1) AU734829B2 (pt)
BR (1) BR9811992A (pt)
CA (1) CA2301182A1 (pt)
DE (1) DE19736772A1 (pt)
HU (1) HUP0003500A3 (pt)
ID (1) ID23952A (pt)
NO (1) NO20000860L (pt)
PL (1) PL341090A1 (pt)
RU (1) RU2200166C2 (pt)
SK (1) SK2132000A3 (pt)
TW (1) TW477793B (pt)
WO (1) WO1999010371A2 (pt)
ZA (1) ZA987558B (pt)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA43823C2 (uk) * 1992-07-06 2002-01-15 Мерк Патент Геселлшафт Міт Бесшренктер Хафтунг ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ДЛЯ ІНГІБУВАННЯ ІНТЕГРИН <font face="Symbol">a</font><sub>V</sub><font face="Symbol">b</font><sub>3</sub>-ОПОСЕРЕДКОВАНОЇ КЛІТИННОЇ АДГЕЗІЇ КЛІТИН ССАВЦІВ, СПОСІБ ЛІКУВАННЯ ТА ПРОФІЛАКТИКИ ЗАХВОРЮВАННЯ, АСОЦІЙОВАНОГО З ПОРУШЕННЯМ АДГЕЗІЇ КЛІТИН, СПОСІБ БЛОКУВАННЯ ЗВ'ЯЗУВАННЯ ФІБРИНОГЕНОМ ІНТЕГРИНУ, КОМПОЗИЦІЯ ДЛЯ ЗАГОЄННЯ РАН
DE4310643A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
DE4415310A1 (de) * 1994-04-30 1995-11-02 Merck Patent Gmbh Cyclopeptide
JPH07316193A (ja) * 1994-05-24 1995-12-05 Asahi Glass Co Ltd ペプチド誘導体およびその用途

Also Published As

Publication number Publication date
NO20000860D0 (no) 2000-02-22
TW477793B (en) 2002-03-01
RU2200166C2 (ru) 2003-03-10
ID23952A (id) 2000-06-08
WO1999010371A2 (de) 1999-03-04
AU9531998A (en) 1999-03-16
SK2132000A3 (en) 2000-09-12
WO1999010371A3 (de) 1999-05-27
CA2301182A1 (en) 1999-03-04
EP1007545A2 (de) 2000-06-14
NO20000860L (no) 2000-02-22
BR9811992A (pt) 2000-09-05
CN1267306A (zh) 2000-09-20
KR20010022828A (ko) 2001-03-26
AR013650A1 (es) 2001-01-10
HUP0003500A3 (en) 2001-12-28
ZA987558B (en) 1999-02-23
DE19736772A1 (de) 1999-02-25
AU734829B2 (en) 2001-06-21
JP2001514186A (ja) 2001-09-11
HUP0003500A2 (hu) 2001-02-28

Similar Documents

Publication Publication Date Title
GR3033293T3 (en) Cyclic adhesion inhibitors
PL324527A1 (en) Cyclic inhibitors of gmp-specific phosphodisterase
PL339551A1 (en) Derivatives of rezorcin
AUPP616498A0 (en) Synthesis of cyclic peptides
PL334846A1 (en) Sulphamidic inhibitors of metaloproteases
PL337645A1 (en) Novel amidine derivatives and their application as thrombosin inhibitors
AU2568897A (en) Cyclic adhesion inhibitors
AU772782C (en) Cyclic peptide derivatives as inhibitors of integrin alphavbeta6
ZA983065B (en) Inhibitors of protein farnesyltranferase
AU8673598A (en) Neuraminidase inhibitors
PL355811A1 (en) Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h
AU2241699A (en) Expression of proteolytically-sensitive peptides
PL334769A1 (en) Derivatives of 5-aroylnaphtene
AUPP182398A0 (en) Cyclic peptide inhibitors of pla2
ZA9711392B (en) Cyclic peptide derivatives
PL341090A1 (en) Cyclic derivatives of peptides as adhesion inhibitors
ZA985064B (en) Derivatives of pentaerythrits
PL325816A1 (en) Novel derivatives of naphtylpiperazine
GB9727216D0 (en) Cyclic amino acid derivatives as cell adhesion inhibitors
SI0904285T1 (en) Cyclic adhesion inhibitors
ZA944921B (en) Peptide inhibitors of cell adhesion
IL110221A0 (en) Peptide inhibitors of cell adhesion
AU2604299A (en) Cyclic peptide inhibitors of pla2
FI943259A0 (fi) Soluadheesion peptidi-inhibiittorit
AU682036B2 (en) Peptide inhibitors of cell adhesion